Trademark: 79334635
Word
OLIX
Status Date
Tuesday, July 9, 2024
Registration Number
7435162
Registration Date
Tuesday, July 9, 2024
Filing Date
Friday, December 24, 2021
Published for Opposition
Tuesday, April 23, 2024
5 Dietary supplements; nucleic acid sequences for medical purposes; cultures of microorganisms for medical use; biotechnological preparations for medical use, namely, cells, recombinant DNA sequences, synthetic RNA sequences, and oligonucleotides for use in treating and repairing damaged human tissue through tissue nanotransfection (TNT); reagent paper for medical purposes; drugs for medical purposes, namely, cardiovascular pharmaceuticals, anti-diabetic pharmaceuticals, metabolic pharmaceuticals, antibacterial pharmaceuticals, macular degeneration treatment pharmaceuticals (or ophthalmic pharmaceuticals), hair loss treatment pharmaceuticals, hepatitis treatment pharmaceuticals, respiratory disease treatment pharmaceuticals, neurological disease treatment pharmaceuticals, hepatological disease treatment pharmaceuticals; synthetic peptides for the treatment of metabolic, ophthalmic, cardiovascular, pulmonary, hepatological, respiratory, neurological diseases and disorders; cardiovascular pharmaceuticals, anti-diabetic pharmaceuticals, antibacterial pharmaceuticals, macular degeneration treatment pharmaceuticals (or ophthalmic pharmaceuticals), hair loss treatment pharmaceuticals, hepatitis treatment pharmaceuticals, respiratory disease treatment pharmaceuticals, neurological disease treatment pharmaceuticals, hepatological disease treatment pharmaceuticals; materials for dental fillings; colostral antibodies for medical purposes, monoclonal antibodies for medical purposes, hybrid antibodies for medical purposes; all the foregoing for human use and excluding goods related to the care and feeding of animals and plants
42 Product research and development in the field of biotech technology; scientific research in the field of biotechnology, medical research in the field of biotechnology; scientific research and scientific investigations for medical purposes in the field of biomedicine; scientific research consultation and providing scientific research information both of the foregoing in the field of biomedicine; bacteriological research; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; pharmaceutical research services; scientific research in the field of genetics; medical research laboratory services; Scientific research and scientific investigations for medical purposes, both of the foregoing in the fields of medicine, health and pharmacology; medical research; All the above-mentioned services excluding services related to the care and feeding of animals and plants
Mar 3, 2022
Sn Assigned For Sect 66a Appl From Ib
Mar 10, 2022
New Application Office Supplied Data Entered
Mar 15, 2022
Application Filing Receipt Mailed
Jul 23, 2022
Correction Transaction Received From Ib
Sep 28, 2022
Assigned To Examiner
Sep 28, 2022
Non-Final Action Written
Sep 29, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Oct 1, 2022
Limitation Of Goods Received From Ib
Oct 28, 2022
Correction From Ib Entered - Attorney Review Required
Dec 12, 2022
Refusal Processed By Mpu
Dec 12, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jan 4, 2023
Refusal Processed By Ib
Jan 12, 2023
Limitation From The Ib - Request Exam Review
Feb 1, 2023
Attorney Review Completed
May 2, 2023
Teas Response To Office Action Received
May 2, 2023
Correspondence Received In Law Office
May 3, 2023
Teas/Email Correspondence Entered
May 24, 2023
Final Refusal Written
May 24, 2023
Final Refusal E-Mailed
May 24, 2023
Notification Of Final Refusal Emailed
Nov 21, 2023
Teas Request For Reconsideration Received
Nov 21, 2023
Correspondence Received In Law Office
Nov 22, 2023
Teas/Email Correspondence Entered
Dec 27, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Dec 27, 2023
Notification Of Possible Opposition Sent To Ib
Jan 8, 2024
Action Continuing A Final - Completed
Jan 8, 2024
Continuation Of Final Refusal E-Mailed
Jan 8, 2024
Notification Of Subsequent Final Emailed
Jan 13, 2024
Notification Of Possible Opposition - Processed By Ib
Feb 6, 2024
Teas Request For Reconsideration Received
Feb 6, 2024
Correspondence Received In Law Office
Feb 7, 2024
Teas/Email Correspondence Entered
Mar 12, 2024
Approved For Pub - Principal Register
Apr 3, 2024
Notification Of Notice Of Publication E-Mailed
Apr 10, 2024
Notification Of Possible Opposition Sent To Ib
Apr 10, 2024
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 23, 2024
Published For Opposition
Apr 23, 2024
Official Gazette Publication Confirmation E-Mailed
Jul 9, 2024
Registered-Principal Register
Jul 9, 2024
Notice Of Registration Confirmation Emailed
Apr 29, 2024
Notification Processed By Ib
Trademark Alertz updated from USPTO on 2030-01-24
